| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.008 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |